In addition, other authors have reported better prognosis in CC homozygous patients of IL-6 promoter polymorphism (-174 G/C) in various diseases, such us different types of cancer, surgical coronary revascularization and end-stage renal disease on hemodialysis [10,11,12,13,14]. This evidence concerns the gene IL6 and stage 5 chronic kidney disease.